The Economic Burden of Congenital Cytomegalovirus Disease in the First Year of Life: A Retrospective Analysis of Health Insurance Claims Data in the United States
Authors:
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 41 (6) , 1040-1056.e3
Abstract
No abstract availableKeywords
Funding Information
- Merck Sharp & Dohme Corp.
- Merck Sharp & Dohme Corp
This publication has 19 references indexed in Scilit:
- Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based surveyBMC Women's Health, 2014
- Congenital Cytomegalovirus-related Hospitalizations in Infants <1 Year of Age, United States, 1997–2009The Pediatric Infectious Disease Journal, 2014
- Intrauterine Growth Restriction Caused by Underlying Congenital Cytomegalovirus InfectionThe Journal of Infectious Diseases, 2014
- Congenital Cytomegalovirus Infection: Clinical OutcomeClinical Infectious Diseases, 2013
- Influence of infection during pregnancy on fetal developmentReproduction, 2013
- The “Silent” Global Burden of Congenital CytomegalovirusClinical Microbiology Reviews, 2013
- Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategiesJournal of Antimicrobial Chemotherapy, 2009
- Seroprevalence of Cytomegalovirus Infection in the United States, 1988-1994Clinical Infectious Diseases, 2006
- Congenital cytomegalovirus (CMV) infection and hearing deficitJournal of Clinical Virology, 2006
- Associations between measures of socioeconomic status and low birth weight, small for gestational age, and premature delivery in the United StatesAnnals of Epidemiology, 1994